Reade Gout cohort Cardiovascular risk & management in gout patients
Recruiting
- Conditions
- Gout1002321310003216
- Registration Number
- NL-OMON44794
- Lead Sponsor
- Jan van Breemen Instituut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Patients:
- Aged 18 years or older
- Diagnosis of gout (first or recurrent episode) confirmed by a rheumatologist
Exclusion Criteria
No informed consent
Insufficient language proficiency
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To assess the prevalence of cardiovascular disease<br /><br>To assess the prevalence of risk factors for cardiovascular disease<br /><br>To quantify the risk for cardiovascular disease in patients with gout.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To investigate the impact of cardiovascular risk management on the risk for<br /><br>cardiovascular disease in patients with gout in patients who need CV-RM<br /><br>according to the Dutch guidelines one year after the baseline visit.<br /><br>To collect more information about the vascular status of patients with<br /><br>tophaceus gout and contribution of inflammasome activation and oxidative stress<br /><br>on the atherosclerotic process. </p><br>